Polyarteritis nodosa
Also known as: PAN, Systemic polyarteritis nodosa, Classic polyarteritis nodosa, Necrotising medium-vessel vasculitis
Polyarteritis nodosa (PAN) is a potentially serious necrotising vasculitis primarily involving medium-sized arteries, with possible cutaneous, peripheral nerve, gastrointestinal, and renal vascular involvement. Diagnosis, disease-activity assessment, and treatment require specialist medical care; traditional Chinese medicine (TCM) must not delay immunosuppression or other indicated treatments. Adjunctive consultations may address stable residual pain, fatigue, sleep disturbance, and coping following medical assessment. the cited evidence includes one PAN case report describing remission achieved with cyclophosphamide and corticosteroids, not Chinese medicine. Other records concern occult hepatitis B, a different vasculitis, and dermatological diagnostic technology. None of the supplied records assesses acupuncture or herbal treatment for PAN. The patterns below are traditional assessment frameworks, not validated PAN subtypes or evidence of disease-modifying benefit.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere strictly to specialist consultations, prescribed pharmacological regimens, and diagnostic pathology monitoring. Patients must not modify corticosteroid dosages independently.
- •Maintain a systematic symptom log to document pain, cutaneous changes, walking tolerance, sleep, and body temperature when unwell.
- •Ensure consistent nutritional intake; consult clinical dietetics for anorexia. Strictly observe fluid restriction or renal dietary protocols as dictated by medical specialists.
- •Cessation of tobacco use is mandatory. Protect anaesthetic or paraesthetic areas of the integument from thermal or mechanical trauma. Balance low-impact physical activity with adequate physiological rest.
Cautions & Contraindications
- •Defer elective acupuncture and herbal initiation during suspected active systemic disease, new neurological deficits or unexplained abdominal pain until medically assessed. This is a conservative clinical precaution informed by the organ involvement described in the PAN case, not a tested acupuncture contraindication from that report.[]
- •Do not needle through vasculitic lesions, ulcers, infected skin or poorly perfused tissue. Seek medical assessment of uncertain lesions; the supplied pathology study supports diagnostic complexity, not acupuncture safety claims.[]
- •Do not introduce herbs during unexplained fever, liver deterioration or suspected hepatitis activity before medical review. Inform the prescribing team of known HBV history; the supplied occult-HBV case does not establish a PAN-specific screening or herbal safety protocol.[]
When to reassess or seek care again
If the specialist agrees that disease is stable, review adjunctive care after 2–4 weeks using a 0–10 pain score, fatigue score, sleep duration, walking tolerance and adverse-event record. Continue specialist-directed blood pressure, laboratory and organ monitoring independently of symptom improvement. Stop ineffective adjunctive treatment at review; refer sooner for worsening function, new skin lesions, fever, weight loss or neurological changes, and use emergency pathways for red flags.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- BMJ case reports · 2026
- IDCases · 2026
- Clinical case reports · 2026
- Scientific reports · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
